Brendan Hannah

Chief Business Officer, IRulya Therapeutics Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 5, 2025Exercised options 25,280 shares at $0.94 of IRulya Therapeutics Inc.³
Dec 5, 2025Exercised options 2,271 shares at $0.55 of IRulya Therapeutics Inc.³
Jun 18, 2025Granted 37,736 shares at $1.20 of IRulya Therapeutics Inc.⁴
Aug 21, 2024Bought 23,565 shares at $0.63 of IRulya Therapeutics Inc.⁵
Aug 21, 2024Bought 5,000 shares at $0.62 of IRulya Therapeutics Inc.⁵
Aug 21, 2024Bought 2,280 shares at $0.61 of IRulya Therapeutics Inc.⁵
Aug 20, 2024Bought 3,424 shares at $0.60 of IRulya Therapeutics Inc.⁵
Aug 20, 2024Bought 2,500 shares at $0.61 of IRulya Therapeutics Inc.⁵
Aug 19, 2024Bought 2,155 shares at $0.58 of IRulya Therapeutics Inc.⁵
Jun 4, 2024Exercised options 56,061 shares at $0.55 of IRulya Therapeutics Inc.⁶
Aug 8, 2023Bought 71,762 shares at $1.22 of IRulya Therapeutics Inc.⁷
May 19, 2022Granted 113,569 shares of IRulya Therapeutics Inc.⁸
May 19, 2022Granted 16,224 shares of IRulya Therapeutics Inc.⁹

The numbers on this page point here. Each one links to the record it came from.